Chloride ion

Generic Name: Chloride ion

Drug Type: Small Molecule

Chemical Formula: Cl

CAS Number: 16887-00-6

Unique Ingredient Identifier: Q32ZN48698

Clinical Trials

Nebulized 3% Hypertonic Saline Solution Treatment of Bronchiolitis in Infants

Phase 4

Completed

Conditions: Bronchiolitis
Wheezing

Interventions: Drug: 0.9% Sodium Chloride
Drug: 3% Sodium Chloride

First Posted Date: 2014-09-09

Last Posted Date: 2017-06-21

Lead Sponsor: Coordinación de Investigación en Salud, Mexico

Target Recruit Count: 64

Registration Number: NCT02233985

Locations: 🇲🇽
Unidad Medica de Alta Especialidad Bajío No. 48 Hospital de Gineco - Pediatría. Instituto Mexicano del Seguro Social, Leon, Guanajuato, Mexico

Personalized Versus Standard Hydration for Prevention of CI-AKI: a Randomized Trial With Bioimpedance Analysis

Phase 4

Completed

Conditions: Acute Kidney Injury

Interventions: Drug: sodium chloride infusion

First Posted Date: 2014-08-26

Last Posted Date: 2015-10-16

Lead Sponsor: Ospedale Misericordia e Dolce

Target Recruit Count: 296

Registration Number: NCT02225431

Locations: 🇮🇹
Ospedale Santo Stefano, Prato, Italy

Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of BI 653048 BS H3PO4 Capsule Assessing Endotoxin-induced Inflammatory Response in Healthy Male Subjects

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Prednisolone high
Drug: Placebo
Drug: BI 653048 BS
Drug: Prednisolone low
Drug: sodium chloride infusion
Drug: endotoxin escherichia coli (E. coli) lipopolysaccharide (LPS)

First Posted Date: 2014-08-25

Last Posted Date: 2014-08-25

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 56

Registration Number: NCT02224105

High Dose Atorvastatin for Preventing Contrast-induced Nephropathy

Phase 2

Completed

Conditions: Contrast-Induced Nephropathy

Interventions: Drug: Placebo
Drug: Atorvastatin
Drug: 0.9% sodium chloride

First Posted Date: 2014-04-15

Last Posted Date: 2014-04-15

Lead Sponsor: Isfahan University of Medical Sciences

Target Recruit Count: 250

Registration Number: NCT02114346

Locations: 🇮🇷
Alzahra Hospital, Isfahan, Iran, Islamic Republic of

Efficacy Study of Articaine Lozenge to Enhance the Procedural Compliance of the Adults Undergoing Gastroduodenoscopy

Phase 4

Conditions: Hematemesis
Heartburn
Dyspepsia
Abdominal Pain

Interventions: Drug: Sodium Chloride 0.9%
Drug: Anesthetics, Local

First Posted Date: 2014-04-07

Last Posted Date: 2019-05-06

Lead Sponsor: Helsinki University Central Hospital

Target Recruit Count: 120

Registration Number: NCT02105090

Locations: 🇫🇮
Department of Anesthesiology and Intensive care medicine, Divison of Surgery, Meilahti hospital, Helsinki University Central Hospital, Helsinki, Uusimaa, Finland

Neuroprotection With Dexmedetomidine in Patients Undergoing Elective Cardiac or Abdominal Surgery (Neuprodex)

Phase 4

Completed

Conditions: Delirium
Postoperative Cognitive Deficit (POCD)

Interventions: Drug: Dexmedetomidine (Dexdor®)
Drug: 0.9% Sodium Chloride

First Posted Date: 2014-03-26

Last Posted Date: 2019-09-25

Lead Sponsor: Claudia Spies

Target Recruit Count: 78

Registration Number: NCT02096068

Locations: 🇩🇪
Department of Anesthesiology and Operative Intensive Care Medicine, Campus Charité Mitte and Campus Virchow - Klinikum, Charité- Universitätsmedizin, Berlin, Germany

Theophylline, N-acetylcysteine, and Theophylline Plus N-acetylcysteine in Preventing Contrast-induced Nephropathy

Phase 2

Conditions: Contrast-Induced Nephropathy

Interventions: Drug: N-acetylcysteine
Drug: Theophylline
Drug: 0.9% sodium chloride

First Posted Date: 2014-03-17

Last Posted Date: 2014-03-17

Lead Sponsor: Isfahan University of Medical Sciences

Target Recruit Count: 96

Registration Number: NCT02088502

Locations: 🇮🇷
Chamran Hospital, Isfahan, Iran, Islamic Republic of

The Effect of Intraoperative Ketamine on Opioid Consumption and Pain After Spine Surgery in Opioid-dependent Patients

Phase 4

Completed

Conditions: Chronic Pain
Postoperative Pain
Analgesics

Interventions: Drug: (S)-(+)-Ketamine Hydrochloride Solution 25 mg/ml
Drug: Isotonic sodium chloride 0.9 percent
Drug: Paracetamol 1 g
Drug: Morphine Sulphate 1 mg/ml
Drug: Ondansetron 2 mg/ml
Drug: Usual daily opioids
Drug: Sufentanil 5 microgram/ml

First Posted Date: 2014-03-13

Last Posted Date: 2017-04-28

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 147

Registration Number: NCT02085577

Locations: 🇩🇰
Department of Anaesthesiology, Glostrup Hospital, Glostrup, Denmark

Remifentanil for General Anesthesia in the Context of Immaturity

Phase 1

Conditions: Cesarean Section
Anesthesia

Interventions: Drug: sodium chloride 0,9%
Drug: Remifentanil

First Posted Date: 2014-01-08

Last Posted Date: 2017-08-30

Lead Sponsor: University Hospital, Rouen

Target Recruit Count: 53

Registration Number: NCT02029898

Locations: 🇫🇷
CHU de Rouen, Rouen, France

Phase 2 Study of MP4CO to Treat Vaso-occlusive Sickle Crisis

Phase 2

Withdrawn

Conditions: Anemia, Sickle Cell
Sickle Cell Anemia
Hemoglobin SC Disease
Sickle Cell Disease
Sickle Cell Disorders
Sickle Cell Hemoglobin C Disease

Interventions: Drug: Sodium chloride solution
Drug: MP4CO

First Posted Date: 2013-08-19

Last Posted Date: 2013-10-28

Lead Sponsor: Sangart

Registration Number: NCT01925001

Locations: 🇬🇧
Queen Mary Hospital, London, United Kingdom
🇧🇪
University Hospital Brugmann, Brussels, Belgium
🇱🇧
Univ. Medical Center Rizk Hospital, Beirut, Lebanon

and more 11 locations

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

Home Terms & Conditions Privacy Policy